Biomarkers in Cardiology - Part 1 - In Heart Failure and Specific Cardiomyopathies
- 1 January 2014
- journal article
- Published by Sociedade Brasileira de Cardiologia in Arquivos Brasileiros de Cardiologia
Abstract
No abstract availableThis publication has 46 references indexed in Scilit:
- Serial Measurement of Cardiac Troponin T Using a Highly Sensitive Assay in Patients With Chronic Heart FailureCirculation, 2012
- Impact of Serial Troponin Release on Outcomes in Patients With Acute Heart FailureCirculation: Heart Failure, 2011
- Galectin‐3, cardiac structure and function, and long‐term mortality in patients with acutely decompensated heart failureEuropean Journal of Heart Failure, 2010
- Anti-heart and anti-intercalated disk autoantibodies: evidence for autoimmunity in idiopathic recurrent acute pericarditisHeart, 2010
- Plasma ACE2 Activity is an Independent Prognostic Marker in Chagas' Disease and Equally Potent as BNPJournal of Cardiac Failure, 2010
- Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF studyClinical Research in Cardiology, 2010
- Effects of Statin Therapy According to Plasma High-Sensitivity C-Reactive Protein Concentration in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)Circulation, 2009
- N-terminal pro-B-type natriuretic peptide as a marker of disease severity in patients with pericardial effusionsThe Korean Journal of Internal Medicine, 2008
- Inflammation and long-term mortality in acute congestive heart failureAmerican Heart Journal, 2006
- Is Elevated Plasma B-Natriuretic Peptide in Amyloidosis Simply a Function of the Presence of Heart Failure?The American Journal of Cardiology, 2005